UPDATE 1-GSK exec caught off-guard by China graft charges: sources
(Adds GSK declining to comment, UK Serious Fraud Office) By Adam Jourdan and Kazunori Takada SHANGHAI, May 15 (Reuters) - GlaxoSmithKline Plc executive Mark Reilly had little inkling he would be charged with leading a network of corruption in China's pharmaceutical industry, two sour
Read more